Clinical trial
Induction Treatment of Proliferative Lupus Nephritis With Leflunomide Combined…
NCT00268567 · Peking University, Other · Completed
Key facts
| NCT number | NCT00268567 |
|---|---|
| Title | Induction Treatment of Proliferative Lupus Nephritis With Leflunomide Combined With Prednisone |
| Official title | Phase 3 Study of Leflunomide Combined With Prednisone Treatment of Proliferative Lupus Nephritis as Induction Therapy |
| Lead sponsor | Peking University, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Nephritis, Lupus |
| Intervention type | Drug |
| Interventions | leflunomide combined with prednisone |
| Start date | Oct 1, 2002 |
| First posted | Dec 22, 2005 |
| Last update posted | Dec 22, 2005 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: